MCRB icon

Seres Therapeutics

113 hedge funds and large institutions have $2.42B invested in Seres Therapeutics in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

33% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 30

22% more funds holding

Funds holding: 93113 (+20)

0.05% less ownership

Funds ownership: 4.96%4.91% (-0.05%)

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$83.3M
Puts
$19.3M
Net Calls
Net Calls Change

Top Sellers

1 -$52.9M
2 -$51.4M
3 -$28.8M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$20.9M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.98M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$3.78M
27
$3.44M
28
$3.4M
29
$3.19M
30
$3.1M
31
$3.01M
32
$2.76M
33
$2.7M
34
$2.62M
35
$2.27M
36
$2.09M
37
$2.09M
38
$2.05M
39
$1.95M
40
$1.89M
41
$1.87M
42
$1.8M
43
$1.72M
44
$1.67M
45
$1.51M
46
$1.46M
47
$1.32M
48
$1.26M
49
$1.2M
50
$1.04M